TP53 mutation and microsatellite instability status for the prediction of survival in adjuvant-treated colon cancer patients

被引：1
|
作者：
Watanabe, T [1 ]
Kanazawa, T [1 ]
Kazama, Y [1 ]
Tanaka, J [1 ]
Tanaka, T [1 ]
Ishihara, S [1 ]
Nagawa, H [1 ]
机构：
[1] Tokyo Univ Hosp, Dept Surg Oncol, Tokyo 113, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 35期
关键词：
D O I：
10.1200/JCO.2005.04.0394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9031 / 9032
页数：2
相关论文
共 50 条
  • [1] TP53 mutation and microsatellite instability status for the prediction of survival in adjuvant-treated colon cancer patients -: Reply
    Westra, JL
    Hofstra, RMW
    Schaapveld, M
    Plukker, JTM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) : 9032 - 9033
  • [2] Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients
    Westra, JL
    Schaapveld, M
    Hollema, H
    de Boer, JP
    Kraak, MMJ
    de Jong, D
    ter Elst, A
    Mulder, NH
    Buys, CHCM
    Hofstra, RMW
    Plukker, JTM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5635 - 5643
  • [3] Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients
    B.L. Powell
    S. Bydder
    F. Grieu
    G. Gnanasampanthan
    H. Elsaleh
    R. Seshadri
    E.M.J.J. Berns
    B. Iacopetta
    [J]. Breast Cancer Research and Treatment, 2001, 69 : 65 - 68
  • [4] Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients
    Powell, BL
    Bydder, S
    Grieu, F
    Gnanasampanthan, G
    Elsaleh, H
    Seshadri, R
    Berns, EMJJ
    Iacopetta, B
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (01) : 65 - 68
  • [5] Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer
    Meric-Bernstam, Funda
    Zheng, Xiaofeng
    Shariati, Maryam
    Damodaran, Senthil
    Wathoo, Chetna
    Brusco, Lauren
    Demirhan, Mehmet Esat
    Tapia, Coya
    Eterovic, Agda Karina
    Basho, Reva K.
    Ueno, Naoto T.
    Janku, Filip
    Sahin, Aysegul
    Rodon, Jordi
    Broaddus, Russell
    Kim, Tae-Beom
    Mendelsohn, John
    Shaw, Kenna R. Mills
    Tripathy, Debu
    Mills, Gordon B.
    Chen, Ken
    [J]. JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 15
  • [6] TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients
    Kandioler, Daniela
    Mittlboeck, Martina
    Kappel, Sonja
    Puhalla, Harald
    Herbst, Friedrich
    Langner, Cord
    Wolf, Brigitte
    Tschmelitsch, Joerg
    Schippinger, Walter
    Steger, Guenther
    Hofbauer, Friedrich
    Samonigg, Hellmut
    Gnant, Michael
    Teleky, Bela
    Kuehrer, Irene
    [J]. EBIOMEDICINE, 2015, 2 (08): : 825 - 830
  • [7] TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies
    Ruzinova, Marianna B.
    Lee, Yi-Shan
    Duncavage, Eric J.
    Welch, John S.
    [J]. HAEMATOLOGICA, 2019, 104 (08) : E345 - E348
  • [8] Effect of TP53 mutation status on survival in the MAGIC trial
    Smyth, Elizabeth Catherine
    Wilson, Sanna Hulkki
    Nankivell, Matthew Guy
    de Castro, David Gonzalez
    Wotherspoon, Andrew
    Okines, Alicia Frances Clare
    Langley, Ruth E.
    Stenning, Sally Patricia
    Cunningham, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] Association of PDL1 expression with TP53, KRAS mutation, and microsatellite instability in Indonesian patients with colorectal cancer
    Putra, T. P.
    Kusumo, G. D.
    Budiyati, A.
    Rexana, F.
    Sudoyo, A.
    Kurniawan, A. N.
    Utomo, A. R.
    Utama, A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] TP53 mutations and microsatellite instability are prognostic factors in gastric cancer?
    Corsale, S.
    Agnese, V.
    Augello, C.
    Bruno, L.
    Calcara, D.
    Calo, V.
    Gargano, G.
    Gregorio, V.
    Gullo, A.
    La Paglia, L.
    Schiro, V.
    Terrasi, M.
    Crosta, A.
    Rinaldi, G.
    Tomasino, R. M.
    Morello, V.
    Daniele, E.
    Pantuso, G.
    Fiorentino, E.
    Chiarini, A.
    Martorana, A.
    Bazan, V.
    Russo, A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII148 - VII149
12345